Key Takeaways:
Oklo reported Q2 revenue of $1.2 million, its first-ever quarterly top line, beating the $128,775 consensus by roughly $1.08 million. The advanced nuclear technology company posted an adjusted loss of $0.28 per share, wider than the $0.16 analysts modeled.
Analyst targets remain widely dispersed, with the average across 25 firms polled by S&P Global at $86.95, while Barclays' Christine Cho holds a Buy with a $76 target, cut from $82. The spread reflects the binary nature of regulatory outcomes for the Aurora reactor program.
Net loss widened to $48.5 million from $24.7 million in the year-ago quarter, versus the $25.5 million analysts projected. Research and development expenses climbed to $39.5 million from $11.5 million, while cash and equivalents stood at $1.66 billion, up from $226.8 million.
Shares rose 13.3 percent on Friday, heading for the biggest weekly advance in nearly four months. The stock trades near the bottom of its 52-week range of $44.88 to $193.84, having fallen about 77 percent from its high. The stock had gained about 2.7 percent over the last week before the report.
The company highlighted progress on its Aurora power plants, designed to produce 15-50 MWe with potential expansion to 100 MWe, and its fuel recycling work with the U.S. Department of Energy. Oklo also noted the first site use permit from the DOE for a commercial advanced fission plant and the first custom combined license application submitted to the Nuclear Regulatory Commission for an advanced reactor.
Consensus estimates project Q3 2026 revenue of $242,250 and full-year 2026 revenue of $1.86 million, implying a lower run rate in the second half as contract timing remains lumpy for early-stage project companies. The company did not provide updated financial guidance.
Insider selling continued during the quarter, with co-founders Caroline Cochran and Jacob Dewitte each selling 1,037,788 shares for an estimated $62.4 million, according to Quiver Quantitative data. The cash position of $1.66 billion provides a runway for continued development spending.
Oklo is not the only listed bet on advanced nuclear. NuScale Power, the closest comparable in the small modular reactor space, trades on similar regulatory milestones, and the group tends to move together on policy news rather than individual results.
The revenue milestone signals early commercialization progress for Oklo's fast-fission technology, even as the loss profile reflects heavy pre-commercial spending. The company's pitch centers on dedicated power generation for AI data centers, where the constraint on compute has shifted from chips to electricity. Investors will watch the NRC design-criteria approval and the 1.2-gigawatt Ohio interconnection filing as the next regulatory catalysts.
This article is for informational purposes only and does not constitute investment advice.
